Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011
Mon, June 6, 2011
Sun, June 5, 2011
Sat, June 4, 2011
Fri, June 3, 2011
Thu, June 2, 2011
[ Thu, Jun 02nd 2011 ]: Market Wire
NAREITa?s Investor Forum
Wed, June 1, 2011
Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011
[ Thu, May 26th 2011 ]: Market Wire
GAMCO Issues Senior Notes
Wed, May 25, 2011
Tue, May 24, 2011
Mon, May 23, 2011

H&Q Life Sciences Investors Announces Preliminary Results of Tender Offer

  Copy link into your clipboard //business-finance.news-articles.net/content/201 .. nounces-preliminary-results-of-tender-offer.html
  Print publication without navigation Published in Business and Finance on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider

BOSTON--([ BUSINESS WIRE ])--H&Q Life Sciences Investors (NYSE: HQL) (the aFunda) announced today the preliminary results of its tender offer to acquire up to 35% of its outstanding shares (aSharesa) for cash at a price equal to 98% of the Funda™s net asset value per share as of the close of regular trading on the New York Stock Exchange on the business day immediately following the day the offer expires (the aTender Offera). The Tender Offer expired at 11:59 p.m., Eastern time, on May 31, 2011.

Based on current information, approximately 11,547,395.4354 Shares, or approximately 52% of the Funda™s Shares outstanding, were tendered through the expiration date. Because the number of Shares tendered exceeds 35% of the outstanding Shares, the Fund will purchase properly tendered Shares pro-rata based on the number of Shares properly tendered by each shareholder. Shareholders cannot be assured that all of their tendered Shares will be purchased by the Fund.

No more than 7,796,312 properly tendered Shares will be accepted for cash payment at a price equal to 98% of the Funda™s NAV as of the close of regular trading on the New York Stock Exchange on June 1, 2011. The final number of Shares validly tendered and accepted pursuant to the Tender Offer will be announced at a later date.

H&Q Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry. Hambrecht & Quist Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.

For more information about H&Q Life Sciences Investors, please visit [ www.hqcm.com ].